Literature DB >> 27154353

Odorants specifically modulate chemotaxis and tissue retention of CD4+ T cells via cyclic adenosine monophosphate induction.

Adam A Clark1, Saule Nurmukhambetova2, Xin Li3, Steven D Munger4, Jason R Lees5.   

Abstract

Retention of T cells within affected tissue is a critical component of adaptive immune inflammation. However, the mechanisms involved in T cell retention remain largely undefined. Previous studies revealed the capacity of cAMP signaling to regulate immune cell migration, as well as dynamic regulation of receptors that could induce cAMP production in immune cells. The potential for cAMP to act as a retention signal has been mostly unexplored, partially as a result of this second messenger's well-characterized inhibition of effector function in immune cells. Here, we report that cAMP regulates the tissue retention of mouse T cells at concentrations well below those that inhibited proliferation or decreased acquisition of an effector phenotype. Stimulation of CD4+ T cells with odorants known to be cognate ligands for T cell-expressed olfactory receptors induced cAMP and inhibited chemokine-driven chemotaxis without decreasing T cell proliferation or effector functions. Similar effects were observed following treatment with relatively low concentrations of the cAMP analog Sp-5,6-dichloro-1-β-d-ribofuranosylbenzimidazole-3',5'-monophosphorothioate. Furthermore, pretreatment with odorants or cAMP at concentrations that did not inhibit effector function induced T cell tissue retention in mice by inhibiting chemokine-dependent T cell egress from the footpad to the draining lymph node. Together, these results suggest that odorant receptor-mediated increases in intracellular cAMP can modulate T cell tissue trafficking and may offer new therapeutic targets for controlling T cell tissue accumulation. © Society for Leukocyte Biology.

Entities:  

Keywords:  cell trafficking; extranasal; inflammation

Mesh:

Substances:

Year:  2016        PMID: 27154353      PMCID: PMC5014743          DOI: 10.1189/jlb.1A0914-425RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  54 in total

Review 1.  Regulation of actin-based cell migration by cAMP/PKA.

Authors:  Alan K Howe
Journal:  Biochim Biophys Acta       Date:  2004-07-05

2.  The differential effect of cyclic AMP on lymphocyte stimulation by T- or B-cell mitogens.

Authors:  T L Vischer
Journal:  Immunology       Date:  1976-05       Impact factor: 7.397

Review 3.  Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports.

Authors:  K Graupe; W J Cunliffe; H P Gollnick; R P Zaumseil
Journal:  Cutis       Date:  1996-01

4.  The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics.

Authors:  Levi G Ledgerwood; Girdhari Lal; Nan Zhang; Alexandre Garin; Steven J Esses; Florent Ginhoux; Miriam Merad; Helene Peche; Sergio A Lira; Yaozhong Ding; Yu Yang; Xingxuan He; Edward H Schuchman; Maria L Allende; Jordi C Ochando; Jonathan S Bromberg
Journal:  Nat Immunol       Date:  2007-11-25       Impact factor: 25.606

Review 5.  Genomics of olfactory receptors.

Authors:  Xiaohong Zhang; Stuart Firestein
Journal:  Results Probl Cell Differ       Date:  2009

Review 6.  Phosphodiesterases as targets for modulating T-cell responses.

Authors:  Elisa Bjørgo; Kristine Moltu; Kjetil Taskén
Journal:  Handb Exp Pharmacol       Date:  2011

Review 7.  Cyclic AMP underpins suppression by regulatory T cells.

Authors:  Josef Bodor; Tobias Bopp; Martin Vaeth; Matthias Klein; Edgar Serfling; Thomas Hünig; Christian Becker; Hansjörg Schild; Edgar Schmitt
Journal:  Eur J Immunol       Date:  2012-06       Impact factor: 5.532

8.  Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.

Authors:  J L Jimenez; C Punzón; J Navarro; M A Muñoz-Fernández; M Fresno
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

9.  Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.

Authors:  Tobias Bopp; Christian Becker; Matthias Klein; Stefan Klein-Hessling; Alois Palmetshofer; Edgar Serfling; Valeska Heib; Marc Becker; Jan Kubach; Steffen Schmitt; Sabine Stoll; Hansjörg Schild; Martin S Staege; Michael Stassen; Helmut Jonuleit; Edgar Schmitt
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

10.  Activation of olfactory receptors on mouse pulmonary macrophages promotes monocyte chemotactic protein-1 production.

Authors:  Jing Jing Li; Hock L Tay; Maximilian Plank; Ama-Tawiah Essilfie; Philip M Hansbro; Paul S Foster; Ming Yang
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more
  5 in total

1.  Olfactory receptors contribute to progression of kidney fibrosis.

Authors:  Ali Motahharynia; Shiva Moein; Farnoush Kiyanpour; Kobra Moradzadeh; Moein Yaqubi; Yousof Gheisari
Journal:  NPJ Syst Biol Appl       Date:  2022-02-18

Review 2.  Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons.

Authors:  Maryanne Makredes Senna; Erik Peterson; Ivan Jozic; Jérémy Chéret; Ralf Paus
Journal:  JID Innov       Date:  2022-03-01

3.  The purinergic receptor P2Y11 choreographs the polarization, mitochondrial metabolism, and migration of T lymphocytes.

Authors:  Carola Ledderose; Sophie Bromberger; Christian J Slubowski; Koichiro Sueyoshi; Dilan Aytan; Yong Shen; Wolfgang G Junger
Journal:  Sci Signal       Date:  2020-09-29       Impact factor: 8.192

Review 4.  The Intestinal Fatty Acid-Enteroendocrine Interplay, Emerging Roles for Olfactory Signaling and Serotonin Conjugates.

Authors:  Jocelijn Meijerink
Journal:  Molecules       Date:  2021-03-05       Impact factor: 4.411

5.  Potential depression and antidepressant-response biomarkers in human lymphoblast cell lines from treatment-responsive and treatment-resistant subjects: roles of SSRIs and omega-3 polyunsaturated fatty acids.

Authors:  Phatcharee Chukaew; Alex Leow; Witchuda Saengsawang; Mark M Rasenick
Journal:  Mol Psychiatry       Date:  2020-04-23       Impact factor: 13.437

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.